12 Project Grants have been secured by Queen’s University, totaling over $15 million in funding from the Canadian Institutes of Health Research

Post-doctoral researcher Irsa Wiginton has developed a simple blood test that can track breast cancer progression.

Queen’s researcher Chris Booth was inducted as a Fellow in the Canadian Academy of Health Sciences.

Queen’s has partnered with leading companies and clinical networks on the CanDETECT Supercluster project to advance innovation in cancer detection and treatment.

$30 million in funding from the Canadian Cancer Society ensures that the research conducted by the Canadian Cancer Trials Group continues to have meaningful impact on the lives of people with cancer.

On World Health Day learn more about how Queen's researchers and educators are working to advance better global health for all.

To recognize World Cancer Day, Queen’s is highlighting current partnerships and research projects to develop novel treatments, support better outcomes, and advance quality of life for people with cancer globally.

Clinical trials at Queen’s University help determine life-changing diagnostics, treatments and prevention methods for cancer. In celebration of the 25th anniversary of the Canada Foundation for Innovation (CFI), we are profiling one of our CFI Major Science Initiatives, The Canadian Cancer Trials Group.

Queen’s researcher Christopher Mueller has developed a breast cancer detection test that provides real time response to chemotherapy and early detection of relapse.

Joseph Pater, founding Director of the Canadian Cancer Trials Group, is recognized for a lifetime of work in cancer research.